Anticoagulation for atrial fibrillation in active cancer (Review)-Reference-Cited by-同舟云学术

Anticoagulation for atrial fibrillation in active cancer (Review)

Published:2022-02-17 Issue:4 Volume:23 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Farmakis Dimitrios¹,Papakotoulas Pavlos²,Angelopoulou Eleni³,Bischiniotis Theodoros⁴,Giannakoulas George⁵,Kliridis Panagiotis⁶,Richter Dimitrios⁷,Paraskevaidis Ioannis⁸

Affiliation:

1. Department of Physiology, University of Cyprus Medical School, Nicosia 2029, Cyprus

2. First Department of Clinical Oncology, ‘Theagenio’ Anticancer Hospital, Thessaloniki 546 39, Greece

3. Department of Cardiology, ‘Agioi Anargyroi’ General Oncology Hospital, Athens 145 64, Greece

4. Department of Cardiology, ‘Theagenio’ Anticancer Hospital, Thessaloniki 546 39, Greece

5. Department of Cardiology, AHEPA General Hospital, Aristotle University of Thessaloniki, Thessaloniki 546 21, Greece

6. Department of Cardiology, ‘Agios Savvas’ General Anti‑Cancer Hospital, Athens 115 22, Greece

7. Department of Cardiology, Athens Euroclinic, Athens 115 21, Greece

8. Department of Therapeutics, ‘Alexandra’ General Hospital, National and Kapodistrian University of Athens Medical School, Athens 115 28, Greece

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference97 articles.

1. Anticoagulation for atrial fibrillation in active cancer: What the cardiologists think;Farmakis;Eur J Prev Cardiol,2020

2. Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study;Vedovati;Int J Cardiol,2018

3. Insights into onco-cardiology: Atrial fibrillation in cancer;Farmakis;J Am Coll Cardiol,2014

4. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC;Hindricks;Eur Heart J,2021

5. Baseline hypertension: New insight into the potential predictors of survival in patients with hepatocellular carcinoma;Hu;Int J Cardiol,2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atrial Fibrillation in Active Cancer;JACC: Advances;2024-07

2. Cancer begets atrial fibrillation … and vice versa?;European Heart Journal;2024-06-07

3. When anticoagulation management in atrial fibrillation becomes difficult: Focus on chronic kidney disease, coagulation disorders, and cancer;Blood Reviews;2024-05

4. Atrial Fibrillation Amplifies Heart Failure Risk in Anthracycline Treated Cancer Patients: Stacking Risk Factors in the Vulnerable;The American Journal of Cardiology;2024-05

5. Current Data and Future Perspectives on Patients with Atrial Fibrillation and Cancer;Cancers;2023-11-10